Megan Chui, Ph.D.
About Megan Chui, Ph.D.
Megan Chui, Ph.D., is a Senior Manager of Analytical Development at Travere Therapeutics, where she has worked since 2021. She holds a Ph.D. in Inorganic Chemistry from UC Santa Barbara and has experience as a Graduate Student Researcher at UCSB, along with visiting scholar positions at East China University of Science and Technology and Universidade Estadual Paulista Júlio de Mesquita Filho.
Work at Travere Therapeutics
Megan Chui serves as the Senior Manager of Analytical Development at Travere Therapeutics. She has held this position since 2021, contributing to the company's efforts in developing innovative therapies. Her role involves overseeing analytical methods and ensuring the quality and efficacy of therapeutic products. Travere Therapeutics focuses on addressing unmet medical needs, particularly in rare diseases.
Education and Expertise
Megan Chui holds a Doctor of Philosophy (PhD) in Inorganic Chemistry from the University of California, Santa Barbara, where she studied from 2012 to 2017. She also earned a Bachelor of Science degree in Chemistry and Mathematics from the University of Miami, completing her studies from 2008 to 2012. Additionally, she was a Visiting Scholar at East China University of Science and Technology from 2013 to 2014 and at Universidade Estadual Paulista Júlio de Mesquita Filho in 2016.
Background
Megan Chui's academic journey began at The Branson School, where she studied from 2004 to 2008. Following her high school education, she pursued a BS in Chemistry and Mathematics at the University of Miami. She then transitioned to UC Santa Barbara for her graduate studies, where she engaged in research as a Graduate Student Researcher in the Department of Chemistry and Biochemistry from 2012 to 2017.
Research Experience
During her time at UC Santa Barbara, Megan Chui worked as a Graduate Student Researcher in the Department of Chemistry and Biochemistry for five years. This role involved conducting research in the field of inorganic chemistry, contributing to her expertise and knowledge in analytical development. Her research experience laid the foundation for her current role at Travere Therapeutics.